欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5324/001
药品名称Lumobry 0.25 mg/ml, oplossing, oogdruppels
活性成分
    • Brimonidine tartrate 0.25 mg/ml
剂型Eye drops, solution
上市许可持有人Bausch Health Ireland Limited 3013 Lake Drive, Citywest Business Campus Dublin 24 - D24 PPT3 - Ierland
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Greece (GR)
    • Italy (IT)
    • Poland (PL)
      Lumify
    • Sweden (SE)
    • Slovakia (SK)
    • Norway (NO)
    • Slovenia (SI)
    • Finland (FI)
    • Hungary (HU)
      Lumobry
    • Bulgaria (BG)
      Lumobry 0.25mg/ml eye drops, solurtion
    • Germany (DE)
      Lumobry 0,25 mg/ml Augentropfen, Lösung
    • Croatia (HR)
    • Denmark (DK)
      Lumobry
    • Cyprus (CY)
      Lumify eye drops, solution, 0.25 mg/ml
    • Belgium (BE)
    • France (FR)
    • Czechia (CZ)
      Lumobry
    • Ireland (IE)
    • Spain (ES)
    • Romania (RO)
      Lumobry 0,25 mg picături oftalmice, soluţie
    • Portugal (PT)
    • Austria (AT)
许可日期2022/08/02
最近更新日期2025/06/24
药物ATC编码
    • S01GA Sympathomimetics used as decongestants
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase